Due to COVID-19 concerns, we are RESTRICTING ALL VISITORS except for one essential support person that is necessary to assist with a patient's care.
Please review our Visitor Policy for more information.
Home > Our Services > Cancer Care > Cancer Treatment > Clinical Trials > Clinical Trials Detail
Back to Results
NSABP B-47 A Randomized Phase III Trial of Adjuvant Therapy Comparing
Chemotherapy Alone to Chemotherapy Plus Trastuzumab in Women with Node-Positive
or High-Risk Node-Negative HER2-Low Invasive Breast Cancer
To determine whether the addition of the drug trastuzumab (Herceptin) to
chemotherapy improves invasive disease-free survival in women with resected
node-positive or high-risk node negative breast cancer with reported HER-2 low
by all HER 2 testing performed
RUTLAND REGIONAL MEDICAL CENTER160 Allen Street, Rutland, VT 05701802.775.7111